Learn the skills needed to analyze data and make an impact on health.
![](https://public3.pagefreezer.com:443/content/HHS.gov/17-08-2021T06:42/http://wayback.archive-it.org/3919/20181017144312im_/https:/www.hhs.gov/sites/default/files/cto-subsitebillboard-747x397px-2.jpg)
The of the National Vaccine Advisory Committee, NVAC) has sought broad public input into the scientific research agenda that is being developed by the Centers for Disease Control and Prevention's (CDC) Immunization Safety Office (ISO).
At its , the NVAC Vaccine Safety Working Group discussed outcomes and issues highlighted in three public engagement sessions held earlier in Birmingham, Alabama; Ashland, Oregon; and Indianapolis, Indiana. A summary of the written comments sent to HHS on the CDC ISO research agenda was also discussed.
|
Andy Pavia, MD, Chair, NVAC Vaccine Safety Working Group Overview: Why did you attend a community meeting about vaccine saftey? Duration: 1:24 minutes |
![]() |
Tracy Cron, Birmingham, AL - 1:47 minutes |
![]() |
Toni DiLeo, Ashland, OR - 2:23 minutes |
![]() |
Bernard Richard, Indianapolis, IN - 2:12 minutes |
![]() |
Andy Pavia, MD, Chair, NVAC Vaccine Safety Working Group - 1:24 minutes |
Learn the skills needed to analyze data and make an impact on health.